Conventional chemotherapy is the most common therapeutic method for treating cancer by
the application of small toxic molecules thatinteract with DNA and causecell death …

The conventional chemotherapeutic agents, used for cancer chemotherapy, have major
limitations including non-specificity, ubiquitous biodistribution, low concentration in tumor …

This review is focused on the chemical design and synthesis of polymer‐based drug
delivery systems, in particular with stimuli‐responsive nanoplatforms for cancer treatment …

Nanocarriers based on polymers have attracted much attention to perform drug delivery,
especially in cancer therapy. Although significant advances have been reported, important …

Background: Rapid developments in the field of nanoparticles during the last decades have
led to its increased application in drug delivery approaches. The advantages of nano-based …

Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents
due to their excellent biocompatibility, biodegradability, and structural versatility. The …

The emergence and development of nanomedicine have alleviated problems existing in
traditional chemotherapy drugs, such as short lifetime, concomitant side effects, and weak …

As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a
major research focus. These nanocarriers respond to specific stimulus signals (eg, pH …

Polymer–drug conjugates (PDCs) have shown great promise in enhancing the efficacy and
safety of cancer therapy. These conjugates combine the advantageous properties of both …

Nanoscale polymers systems have dominated the revolution of drug delivery advancement.
Their potential in the fight against cancer is unrivalled with other technologies. Their …